SPOC Biosciences
SPOC Biosciences is a life sciences technology company focused on advancing proteomics through high-plex biosensor chip platforms. The company enables high-throughput, cost-effective protein production and deep characterization of protein interactions using techniques such as cell-free expression and multiplexed SPR biosensing. Their platform accelerates drug discovery, AI-driven drug design, biomarker identification, diagnostics, antibody screening, and vaccine development by generating scalable, high-resolution kinetic datasets suitable for advanced analytics and AI model training.
Industries
N/A
SPOC Biosciences
Products
High-density biosensor chips for parallel production and kinetic profiling of hundreds to thousands of full-length proteins, compatible with surface plasmon resonance and mass spectrometry.
Suite of high-throughput surface plasmon resonance workflows for kinetic screening, affinity ranking, and epitope mapping of antibodies, proteins, and drug candidates.
Pilot project engagements for AI-aided drug discovery partners to access proprietary high-throughput kinetic characterization and data generation.
High-density biosensor chips for parallel production and kinetic profiling of hundreds to thousands of full-length proteins, compatible with surface plasmon resonance and mass spectrometry.
Suite of high-throughput surface plasmon resonance workflows for kinetic screening, affinity ranking, and epitope mapping of antibodies, proteins, and drug candidates.
Pilot project engagements for AI-aided drug discovery partners to access proprietary high-throughput kinetic characterization and data generation.
Services
Provision of proprietary, high-resolution drug–target interaction and kinetic datasets for machine learning development and benchmarking.
In vitro validation of AI-generated drug molecules against protein targets, including kinetic, affinity, and selectivity profiling.
Screening of patient sera or plasma against produced proteomes for quantitative and kinetic immune response profiling.
Provision of proprietary, high-resolution drug–target interaction and kinetic datasets for machine learning development and benchmarking.
In vitro validation of AI-generated drug molecules against protein targets, including kinetic, affinity, and selectivity profiling.
Screening of patient sera or plasma against produced proteomes for quantitative and kinetic immune response profiling.
Expertise Areas
- Proteomics
- Protein production and engineering
- Surface plasmon resonance analytics
- Antibody discovery and optimization
Key Technologies
- Cell-free protein synthesis
- Surface plasmon resonance (SPR) biosensing
- Multiplexed biosensor chip technology
- MALDI-TOF mass spectrometry
Key People
Scientific Advisory Board Member (Harvard Medical School)
Scientific Advisory Board Member (UC Berkeley)
Scientific Advisory Board Member (ASU Biodesign Institute)
Scientific Advisory Board Member (Harvard Medical School)
Scientific Advisory Board Member (UC Berkeley)
Scientific Advisory Board Member (ASU Biodesign Institute)
News & Updates
Achieved simultaneous production and kinetic characterization of up to 2,400 full-length proteins on a single chip, significantly reducing cost and time requirements for proteomic analysis.
Demonstrated plug-and-play compatibility with existing SPR instruments for multiplexed, kinetic analysis of hundreds to thousands of proteins.
Overview of how the nano-factory technology enables high-throughput, cost-effective protein production on biosensor chips.
Insight into the use of biosensor chip technology for high-plex protein production to support scalable proteomics.
Discussion on scalable protein production technologies and their impact on modern proteomics.
External review of low-plex proteomics and scalable protein production utilizing biosensor chips.
Achieved simultaneous production and kinetic characterization of up to 2,400 full-length proteins on a single chip, significantly reducing cost and time requirements for proteomic analysis.
Demonstrated plug-and-play compatibility with existing SPR instruments for multiplexed, kinetic analysis of hundreds to thousands of proteins.
Overview of how the nano-factory technology enables high-throughput, cost-effective protein production on biosensor chips.
Insight into the use of biosensor chip technology for high-plex protein production to support scalable proteomics.
Discussion on scalable protein production technologies and their impact on modern proteomics.
External review of low-plex proteomics and scalable protein production utilizing biosensor chips.